KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Equity (2016 - 2025)

Historic Return on Equity for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.0%.

  • Pfizer's Return on Equity changed 0.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.0% for FY2024, which is 0.0% changed from last year.
  • Pfizer's Return on Equity amounted to 0.0% in Q3 2025, which was down 0.0% from 0.0% recorded in Q2 2025.
  • Over the past 5 years, Pfizer's Return on Equity peaked at 0.02% during Q2 2021, and registered a low of 0.0% during Q4 2021.
  • In the last 5 years, Pfizer's Return on Equity had a median value of 0.0% in 2022 and averaged 0.0%.
  • As far as peak fluctuations go, Pfizer's Return on Equity crashed by -1600bps in 2021, and later changed by 0bps in 2022.
  • Pfizer's Return on Equity (Quarter) stood at 0.0% in 2021, then skyrocketed by 102bps to 0.0% in 2022, then tumbled by -330bps to 0.0% in 2023, then surged by 127bps to 0.0% in 2024, then skyrocketed by 521bps to 0.0% in 2025.
  • Its Return on Equity stands at 0.0% for Q3 2025, versus 0.0% for Q2 2025 and 0.0% for Q1 2025.